Skip to main content
Campath 30 mg/mL injection by Genzyme Corporation
Campath, 30 mg/mL, injection Drug class: CD52-directed Cytolytic Antibody. Available on prescription only. Listed by Genzyme Corporation.
Prescription only

Campath

ALEMTUZUMAB

Listed by Genzyme Corporation

Strength
30 mg/mL
Form
Injection
Route
Intravenous
Class
CD52-directed Cytolytic Antibody

What it contains

  • Alemtuzumab 30 mg/mL

FDA record

Dosage form Injection
Route Intravenous
Drug class CD52-directed Cytolytic Antibody
Approval route BLA — biologic licence
NDC code 58468-0357
FDA application BLA103948
RxNorm concept 828265
Package sizes listed 2
Marketed since November 2009

Other products containing Alemtuzumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

LEMTRADA

ALEMTUZUMAB

Strength
12 mg/1.2mL
Form
Injection, Solution, Concentrate
Class
CD52-directed Cytolytic Antibody
Rx only

Genzyme Corporation

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.